ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment
Full-year 2025 total revenue grew 25% to approximately $764 million Expect full-year 2026 total revenue of $890 million
Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin,...
Total revenue grew $46 million or 30% to $197 million Surgical revenue grew 31% to $177 million Full-year revenue and profitability guidance increased
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results...
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following...
Surgical revenue grew 29% to $168 million Total revenue grew $40 million or 27.5% Full-year revenue and profitability guidance increased ...
This small-cap biotech might be volatile in the short term but could offer genuine long-term upside with its disruptive innovation.